|
Pfizer Completes Acquisition Of Icagen
|
30 October 2011 |
|
Humana and Pfizer Form Research Partnership
|
13 October 2011 |
|
Pfizer Announces Licensing Agreement With Puma Biotechnology
|
06 October 2011 |
|
NABP and Pfizer Partner to Educate Patients About The Flood of Counterfeit Medicines Online
|
30 September 2011 |
|
U.S. Food And Drug Administration Approves Pfizer's XALKORI® (crizotinib)
|
29 August 2011 |
|
Pfizer Announces EMA Acceptance of Regulatory Submissions
|
22 August 2011 |
|
Pfizer Wins Viagra Patent Trial
|
15 August 2011 |
|
NCCN Receives $2M Educational Grant from Pfizer
|
04 August 2011 |
|
Pfizer Reports Second-Quarter 2011 Results
|
02 August 2011 |
|
Pfizer To Acquire Icagen
|
21 July 2011 |
|
Pfizer to Explore Strategic Alternatives for its Animal Health and Nutrition Businesses
|
08 July 2011 |
|
Pfizer and ChemRar to Explore Innovative Medical Research and Development Partnership in Russia
|
01 July 2011 |
|
Pfizer Files with the FDA for Review of Axitinib for Patients with Advanced Renal Cell Carcinoma
|
29 June 2011 |
|
Pfizer Conducts First "Virtual" Clinical Trial Allowing Patients to Participate Regardless of Geography
|
08 June 2011 |
|
Pfizer and Hisun Sign MOU to Establish a Joint Venture
|
03 June 2011 |
|
Pfizer Announces New Strategic Partnerships with ICON and PAREXEL International Corporation
|
27 May 2011 |
|
SUTENT® Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
|
21 May 2011 |
|
Pfizer To Present New Research From Fifteen Compounds
|
17 May 2011 |
|
Pfizer Reports First-Quarter 2011 Results
|
04 May 2011 |
|
Pfizer Announces Top-Line Results of Final Two Pivotal Phase 3 Trials of Tofacitinib (CP-690,550)
|
29 April 2011 |